Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-04-29

Clinical Trial Update: Comparison of Oral Aprepitant and Transdermal Scopolamine for Preventing Postoperative Nausea and Vomiting [NA]

View source ↗

Summary

This clinical trial compared oral aprepitant with a transdermal scopolamine patch for preventing postoperative nausea and vomiting, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aprepitant (aprepitant)
  • Transdermal scopolamine patch (scopolamine)

Snippet

Sponsor: Drexel University College of Medicine | Conditions: Nausea, Vomiting | NA | Status: COMPLETED | Results posted: 2014-04-29